Pune, Aug. 28 -- The Food and Drugs Administration (FDA) of Maharashtra on Friday cancelled the Carry and Forwarding (C&F) drug sale licences of a prominent pharmaceutical firm located in Wadki, Pune, with effect from August 27, citing multiple regulatory violations.

The action came after an FDA raid conducted in June this year at the firm's warehouse, where a Schedule H prescription drug stock worth Rs 11.19 lakh was seized.

According to the Maharashtra FDA, the packaging of the prescription medicine carried unauthorised advertising text promoting it as an "analgesic & antipyretic".

The FDA said such unauthorised promotion of prescription medicines could encourage self-medication and pose a risk to public health. The firm was also fou...